Rituximab in a child with relapsed Burkitt lymphoma.
Bay
Ali
A
Dogan
Murat
M
Acikgoz
Mehmet
M
Oner
Ahmet Faik
AF
D000005:Abdomen; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D002610:Cheek; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007167:Immunotherapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab